Fluorinated glucosamine has been shown to block the synthesis of key carbohydrate structures linked to cancer progression via interference with UDP-GlcNAc synthesis. The anomerically racemic 4-F-GlcNAc is an inhibitor of hepatic glycosaminoglycan biosynthesis and used as a probe for the study of protein-carbohydrate interactions.